Verification of an assay for quantification of hepatitis C virus RNA by use of an analyte-specific reagent and two different extraction methods

Journal of Clinical Microbiology

Volumn 42, Issue 8, 2004, Pages 3581-3588

  Forman, Michael S ^a   Valsamakis, Alexandra ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALYTE SPECIFIC REAGENT; REAGENT; UNCLASSIFIED DRUG;

ARTICLE; ASSAY; AUTOMATION; CONTROLLED STUDY; CORRELATION ANALYSIS; GENOTYPE; HEPATITIS C VIRUS; INSTRUMENT; INTERMETHOD COMPARISON; NONHUMAN; PERFORMANCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; RNA EXTRACTION; VIRUS DETECTION; VIRUS GENE;

AUTOMATION; CALIBRATION; GENOTYPE; HEPACIVIRUS; INDICATORS AND REAGENTS; LOD SCORE; REGRESSION ANALYSIS; REPRODUCIBILITY OF RESULTS; RNA, VIRAL; SENSITIVITY AND SPECIFICITY;

HEPATITIS C VIRUS; RNA VIRUSES;

EID: 3843099359     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.42.8.3581-3588.2004     Document Type: Article

References (8)

1. Corbet, S., J. Bukh, A. Heinsen, and A. Fomsgaard. 2003. Hepatitis C virus subtyping by a core-envelope 1-based reverse transcriptase PCR assay with sequencing and its use in determining subtype distribution among Danish patients. J. Clin. Microbiol. 41:1091-1100.
2. Fried, M. W., M. L. Shiffman, K. R. Reddy, C. Smith, G. Marinos, F. L. Goncales, Jr., D. Haussinger, M. Diago, G. Carosi, D. Dhumeaux, A. Craxi, A. Lin, J. Hoffman, and J. Yu. 2002. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N. Engl. J. Med. 347:975-982.
3. Hadziyannis, S. J., H. Sette, Jr., T. R. Morgan, V. Balan, M. Diago, P. Marcellin, G. Ramadori, H. Bodenheimer, Jr., D. Bernstein, M. Rizzetto, S. Zeuzem, P. J. Pockros, A. Lin, and A. M. Ackrill. 2004. Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose. Ann. Intern. Med. 140:346-355.
4. Lee, S. C., A. Antony, N. Lee, J. Leibow, J. Q. Yang, S. Soviero, K. Gutekunst, and M. Rosenstraus. 2000. Improved version 2.0 qualitative and quantitative AMPLICOR reverse transcription-PCR tests for hepatitis C virus RNA: calibration to international units, enhanced genotype reactivity, and performance characteristics. J. Clin. Microbiol. 38:4171-4179.
5. Manns, M. P., J. G. McHutchison, S. C. Gordon, V. K. Rustgi, M. Shiffman, R. Reindollar, Z. D. Goodman, K. Koury, M. Ling, and J. K. Albrecht. 2001. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet 358:958-965.
6. Mellor, J., A. Hawkins, and P. Simmonds. 1999. Genotype dependence of hepatitis C virus load measurement in commercially available quantitative assays. J. Clin. Microbiol. 37:2525-2532.
7. NCCLS. 2003. Quantitative molecular methods for infectious diseases. Approved guideline. NCCLS document MM6-A. NCCLS, Wayne, Pa.
8. Pisani, G., K. Cristiano, M. Wirz, G. M. Bisso, and G. Gentili. 2002. Over-estimation of the hepatitis C virus RNA content of reference preparations by the AMPLICOR HCV monitor test, version 2.0. J. Clin. Microbiol. 40:4765-4767.